Physician Payment Sunshine Act: Link to Open Payment Resources
With the Open Payments Website (the website of the program at the Centers for Medicare and Medicaid Services to implement the…
Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Monthly Archives
October 2013
Massachusetts Hearing on Restricting Interactions with Physician and…
On Tuesday, October 1st, 2013, the Joint Committee on Public Health of the Massachusetts Legislature held a public hearing on a…
Health IT: White House Office of National Coordinator Issues Surveillance…
According to a report at FierceEMR, The Office of the National Coordinator of Health IT has issued its first surveillance guidance…
CME: Drop in Federal Government Attendance at Meetings and Conventions…
This past week the government shut down has caused at least one meeting the Regulatory Affairs Professionals Society convention in…
Physician Payment Sunshine: Understanding Indirect and Third Party…
On Tuesday, October 8 at 1:00 pm EDT, the law firm Norton Rose Fulbright will be hosting: "Indirect and third-party payments under…
NIH and Other Public Private Partnerships to Research Treatments for…
Over the past few weeks, the National Institutes of Health (NIH) has made a number of important announcements regarding…
FDA: The Growing Use of Freedom of Information Act Requests for FDA Data by…
The Wall Street Journal reported on the use of FOIA (Freedom of Information Act) requests by investment firms with the intent to…
Continuing Medical Education Courses Decreased Antibiotic Use in Italy
Inappropriate and unnecessary antibiotic prescribing has contributed greatly to a worldwide problem of antimicrobial resistance.…
FDLI 2013: Insights in Enforcement, Litigation & Compliance for…
The Food and Drug Law Institute (FDLI) recently held its annual Advertising & Promotion Conference, which included in-depth…
FDA-EMA Meeting on Orphan Drug Development: Offers Overview of Program and…
The Food and Drug Administration (FDA) recently announced its Office of Orphan Products Development will be holding a meeting…